Hugel will unveil its major product portfolio at the AMWC KOREA, the first global aesthetic medical conference held in South Korea. This event is seen as an opportunity to showcase the global status of K-Aesthetic.
From June 19 to 20, Hugel will participate in the Aesthetic & Anti-aging Medicine World Congress KOREA (AMWC KOREA) at the Grand InterContinental Seoul Parnas.
At the event, Hugel will have a dedicated booth featuring key products including botulinum toxin, Letybo, HA fillers, Revolax bioregenerative skin boosters, HA (BYRYZN) sutures, and Licellvi.
On June 19, a lunch symposium will feature presentations from Kim Se-jin, director of Myeongdong Liens Plastic Surgery Clinic, and Jang Hyo-seung, director of the Gangnam Pierbom Clinic, who will share their clinical experiences and insights on toxin procedures. Following this, Dr. Suneel Chilukuri, founder of Refresh Dermatology in the U.S., will present his experiences and clinical cases involving Letybo treatments in the United States.
In addition to the conference, Hugel plans to offer various programs that allow participants to experience the medical aesthetic scene in Korea. From June 17 to 18, the AMWC KOREA with L.E.A.D educational program will include clinic tours and live demonstrations, followed by the 'Hugel Lead Night' networking event for global medical professionals on the final day, June 20.
Carrie Strom, Hugel's global CEO, stated, "AMWC KOREA is expected to be a meaningful opportunity for Hugel's clients and employees to gather and share market experiences and insights from various regions, enhancing global business synergy."
Meanwhile, as the global status of K-Aesthetic rises, Hugel reported simultaneous growth in revenue and profitability in the first quarter of this year, driven by expansion in overseas markets.
Specifically, Hugel recorded consolidated revenues of 116.6 billion won, operating profit of 47.6 billion won, and net profit of 40.6 billion won for the first quarter. Compared to the same period last year, revenues increased by 29.9%, operating profit by 22.3%, and net profit by 31.5%. Notably, the operating profit margin stood at 40.8%, reflecting strong profitability.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.